US Patent Issued to Phylaxis Bioscience, Inhibrx Biosciences on Feb. 25 for "IgE binding proteins and uses thereof" (California, Colorado Inventors)

ALEXANDRIA, Va., Feb. 26 -- United States Patent no. 12,234,297, issued on Feb. 25, was assigned to Phylaxis Bioscience LLC (Denver) and Inhibrx Biosciences Inc. (La Jolla, Calif.).

"IgE binding proteins and uses thereof" was invented by Bryan R. Becklund (San Diego), Kyle S. Jones (San Marcos, Calif.), Andrew M. Eckles (La Jolla, Calif.), Brendan P. Eckelman (Encinitas, Calif.) and Tony Dung-Ling Yao (Denver).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are IgE-binding VHH domains, polypeptides, and proteins, and methods of using such IgE-binding polypeptides and proteins to modulate the biological activity of IgE."

The patent was filed on Aug. 2, 2024, under Application No. 18/792,921.

*...